IDEXX Laboratories, Inc. (IDXX)
NASDAQ · Healthcare · Medical - Diagnostics & Research
Profile
IDEXX Laboratories, Inc.
- Exchange
- NASDAQ
- Ticker
- IDXX
- Sector
- Healthcare
- Industry
- Medical - Diagnostics & Research
- Country
- US
IDEXX Laboratories, Inc. is a global enterprise focused on creating, producing, and distributing a wide array of products and services. Its primary client base includes companion animal veterinary practices, the livestock and poultry industries, dairy operations, and water quality testing sectors. The company organizes its operations across several key divisions: the Companion Animal Group (CAG), Water Quality Products, Livestock, Poultry, and Dairy (LPD), and additional segments. For companion animals, IDEXX offers a comprehensive suite of point-of-care veterinary diagnostic tools, such as instruments, consumables, and rapid assay kits. It also provides reference laboratory diagnostic and consultation services, alongside practice management and diagnostic imaging solutions for veterinarians. Furthermore, the company supports the biomedical research community with health monitoring, biological materials testing, and laboratory animal diagnostic instruments and services. In the livestock, poultry, and dairy markets, IDEXX supplies diagnostic and health-monitoring solutions. Its water testing portfolio includes products designed to detect various microbiological contaminants, notably the Colilert, Colilert-18, and Colisure tests for total coliforms and E. coli, as well as Enterolert, Pseudalert, Filta-Max, Filta-Max xpress, Legiolert, and Quanti-Tray products. Beyond these, IDEXX extends its reach to human point-of-care medical diagnostics, offering electrolyte and blood gas analyzers, and SARS-CoV-2 RT-PCR tests. Other key offerings encompass in-clinic chemistry, blood and urine chemistry, hematology, and SediVue Dx analyzers, as well as SNAP rapid assay test kits. Veterinary software and services for both independent clinics and large corporate veterinary groups are also part of its offerings. The company distributes its extensive product and service catalog through its own dedicated marketing, customer service, sales, and technical service teams, supplemented by independent distributors and other resellers. IDEXX Laboratories, Inc. was established in 1983 and maintains its headquarters in Westbrook, Maine.
Key facts
IDEXX Laboratories, Inc.: key facts
- IDEXX Laboratories, Inc. (NASDAQ: IDXX) is a Medical - Diagnostics & Research company in the Healthcare sector.
- In fiscal 2025, IDEXX Laboratories, Inc. reported revenue of $4.3B and net income of $1.1B.
- Revenue grew 7.6% a year over the last 4 fiscal years.
- Free cash flow was positive in 5 of the last 5 fiscal years.
- Net income was positive in 5 of the last 5 fiscal years.
- Over the last twelve months, revenue was $4.6B and net income was $1.1B.
MonkScore
IDEXX Laboratories, Inc.'s MonkScore
MonkScore
MonkScore range: 90–100
as of October 2026
Sector rank: 1 of 628 in Healthcare
How this score is madeDisclaimer
Pillar ranges
- Growth90–100
- Profitability90–100
- Quality90–100
- Market Conviction90–100
- Safety90–100
The MonkScore runs from 0 to 100. Each range is one of ten 10-point groups, from 0–10 to 90–100.
Each pillar's range uses the same ten groups. The exact score and the pillar scores are in the MonkStreet app.
Fundamentals
Figures from the statements
IDEXX Laboratories, Inc.'s annual figures and the last twelve months, in USD. Last report: 30 June 2026.
| Figure | Last 12 months | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
| Revenue | $4.6B | $4.3B | $3.9B | $3.7B | $3.4B | $3.2B |
| Gross profit | $2.8B | $2.7B | $2.4B | $2.2B | $2.0B | $1.9B |
| Operating income | $1.5B | $1.4B | $1.1B | $1.1B | $898.8M | $932.0M |
| Net income | $1.1B | $1.1B | $887.9M | $845.0M | $679.1M | $744.8M |
| Operating cash flow | $1.4B | $1.2B | $929.0M | $906.5M | $543.0M | $755.5M |
| Capital expenditure | -$117.2M | -$124.7M | -$130.9M | -$133.6M | -$148.8M | -$119.5M |
| Free cash flow | $1.3B | $1.1B | $798.1M | $772.9M | $394.1M | $636.0M |
| Total debt | $1.1B | $1.1B | $986.9M | $1.1B | $1.5B | $1.0B |
| Cash | $196.9M | $180.1M | $288.3M | $453.9M | $112.5M | $144.5M |
Revenue growth a year
- 1-year
- 10.4%
- 3-year
- 8.5%
- 4-year
- 7.6%
Compound growth between fiscal years.
Peers
Similar companies
- Medpace Holdings, Inc.NASDAQ:MEDPMonkScore range: 90–100
- CareDx, IncNASDAQ:CDNAMonkScore range: 90–100
- Illumina, Inc.NASDAQ:ILMNMonkScore range: 90–100
- Mettler-Toledo International Inc.NYSE:MTDMonkScore range: 90–100
- Agilent Technologies, Inc.NYSE:AMonkScore range: 70–80
- IQVIA Holdings Inc.NYSE:IQVMonkScore range: 70–80
- Sotera Health CompanyNASDAQ:SHCMonkScore range: 70–80
- Quest Diagnostics IncorporatedNYSE:DGXMonkScore range: 70–80
Compare
Compare with
Score my top stocks · 14-day free trial · card required · not charged during the trial · cancel in one click
MonkStreet provides research, not investment advice.
Page built on 31 October 2026.